The bile acid‐sequestering resin sevelamer eliminates the acute GLP‐1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetes

Publisher： John Wiley & Sons Inc

E-ISSN： 1463-1326|20|2|362-369

ISSN： 1462-8902

Source： DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol.20, Iss.2, 2018-02, pp. : 362-369

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Colesevelam hydrochloride: a bile acid sequestrant for glycemic control and treatment of dyslipidemia in Type 2 diabetes mellitus

By Surampudi Prasanth N   Nagireddy Prathima   Fonseca Vivian A  

Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. : 475-487

Future Medicine

Access to resources Recommend Favorite

Liraglutide: a human GLP-1 analog for Type 2 diabetes

By Vilsbøøll Tina  

Therapy, Vol. 6, Iss. 2, 2009-03 ,pp. : 199-207

Future Medicine

Access to resources Recommend Favorite

Dulaglutide: a once‐weekly GLP‐1 for type 2 diabetes

By  

PRESCRIBER, Vol. 26, Iss. 19, 2015-10 ,pp. : 28-30

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of canagliflozin on serum uric acid in patients with type 2 diabetes mellitus

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 4, 2015-04 ,pp. : 426-429

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of duodenal‐jejunal bypass

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 2, 2015-02 ,pp. : 308-315

John Wiley & Sons Inc

Access to resources Recommend Favorite